A detailed history of Apg Asset Management N.V. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Apg Asset Management N.V. holds 133,195 shares of TEVA stock, worth $2.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
133,195
Previous 1,269,396 89.51%
Holding current value
$2.99 Million
Previous $20.6 Million 88.36%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $18 Million - $21.5 Million
-1,136,201 Reduced 89.51%
133,195 $2.4 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $1.44 Million - $1.96 Million
112,481 Added 9.72%
1,269,396 $20.6 Million
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $1.66 Million - $2.25 Million
155,953 Added 15.58%
1,156,915 $16.3 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $458,788 - $600,605
-56,501 Reduced 5.34%
1,000,962 $10.5 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $745,501 - $1.07 Million
-99,666 Reduced 8.61%
1,057,463 $10.8 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $1.16 Million - $1.53 Million
161,632 Added 16.24%
1,157,129 $8.71 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $1.34 Million - $1.82 Million
-160,133 Reduced 13.86%
995,497 $8.81 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $7.54 Million - $8.99 Million
948,004 Added 456.59%
1,155,630 $10.5 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $409,912 - $714,060
59,754 Added 40.41%
207,626 $1.71 Million
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $6.99 Million - $9.84 Million
-946,594 Reduced 86.49%
147,872 $1.06 Million
Q1 2022

May 12, 2022

BUY
$7.33 - $9.39 $50,650 - $64,884
6,910 Added 0.64%
1,094,466 $9.24 Million
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $787,100 - $1.02 Million
99,633 Added 10.09%
1,087,556 $7.66 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $3.77 Million - $4.58 Million
-450,000 Reduced 31.3%
987,923 $8.3 Million
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $5.44 Million - $6.36 Million
549,900 Added 61.92%
1,437,923 $12 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $2.27 Million - $2.81 Million
219,700 Added 32.87%
888,023 $8.72 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $324,545 - $416,141
37,694 Added 5.98%
668,323 $5.27 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $524,484 - $776,628
-61,200 Reduced 8.85%
630,629 $4.85 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $229,795 - $371,296
28,300 Added 4.27%
691,829 $7.6 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $1.94 Million - $3.9 Million
-289,725 Reduced 30.39%
663,529 $5.96 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $6.12 Million - $12.3 Million
915,194 Added 2404.61%
953,254 $13.3 Million
Q4 2019

Feb 13, 2020

SELL
$6.53 - $10.72 $213,589 - $350,640
-32,709 Reduced 46.22%
38,060 $332,000
Q3 2019

Nov 08, 2019

SELL
$6.16 - $9.6 $730,939 - $1.14 Million
-118,659 Reduced 62.64%
70,769 $447,000
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $6.2 Million - $12 Million
-763,826 Reduced 80.13%
189,428 $1.54 Million
Q1 2019

May 14, 2019

BUY
$15.58 - $20.01 $5.29 Million - $6.8 Million
339,669 Added 55.36%
953,254 $13.3 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $6.85 Million - $11.2 Million
469,295 Added 325.24%
613,585 $8.28 Million
Q3 2018

Nov 09, 2018

BUY
$21.06 - $25.65 $171,154 - $208,457
8,127 Added 5.97%
144,290 $2.68 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $1.31 Million - $1.93 Million
-78,201 Reduced 36.48%
136,163 $2.84 Million
Q3 2017

Oct 19, 2017

BUY
$15.41 - $32.17 $3.3 Million - $6.9 Million
214,364
214,364 $3.77 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.